Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
LINCOLN
LINCOLN

Lincoln Pharmaceuticals Ltd.

NSE: LINCOLN
BSE: 531633
Sector: Healthcare
Industry: Pharmaceuticals
585.00-2.3 (-0.39%)
24 Jul, 12:00 AM

Stock Scores

Quality Score

85.7 / 100

Value Score

90.4 / 100

Price Momentum Score

74.5 / 100

QVM Score

99.1 / 100

Key Metrics

Market Cap
1171.76
P/E (TTM)
13.33
P/B
1.55
P/S (TTM)
1.75
EV/EBITDA
9.56
CAPE (5Y)
14.44
ROE (TTM)
12.30
ROCE (TTM)
11.60
ROA (TTM)
10.42
Avg 3Y ROE
14.12
Earnings 3Y CAGR
6.43
Sales 3Y CAGR
9.56
Sales 5Y CAGR
9.61
Debt/Equity
0.01
Consensus TP
1008.00
Strong Buy %
-
Promoter Holding
49.78
Pledged %
0.00

Share Price

Track Lincoln Pharmaceuticals Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: -2.34 %
Low
572.1
High
604.5
1 Month returns: -2.99 %
Low
572.1
High
645.0
1 Year returns: 5.41 %
Low
440.0
High
770.0
3 Year CAGR: 12.60 %
Low
402.9
High
979.5
5 Year CAGR: 9.44 %
Low
255.0
High
979.5
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Lincoln Pharmaceuticals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Lincoln Pharmaceuticals Ltd. Shareholding Pattern

Quarterly breakdown of Lincoln Pharmaceuticals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Lincoln Pharmaceuticals Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Lincoln Pharmaceuticals Ltd.?
The current share price of Lincoln Pharmaceuticals Ltd. is ₹ 585.00 as of 24 Jul 2026.
What is the market capitalisation of Lincoln Pharmaceuticals Ltd.?
The market capitalisation of Lincoln Pharmaceuticals Ltd. stands at ₹ 1,171.76 Cr.
What is the PE ratio of Lincoln Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Lincoln Pharmaceuticals Ltd. is 13.33 as of the latest trailing twelve months data.
What is the ROE and ROCE of Lincoln Pharmaceuticals Ltd.?
Lincoln Pharmaceuticals Ltd. has a Return on Equity (ROE) of 12.30% and a Return on Capital Employed (ROCE) of 11.60% as per the latest financial reports.
What is the 52-week high and low of Lincoln Pharmaceuticals Ltd.?
The 52-week high of Lincoln Pharmaceuticals Ltd. is - and the 52-week low is -.
What is the dividend yield of Lincoln Pharmaceuticals Ltd.?
The dividend yield of Lincoln Pharmaceuticals Ltd. is 0.31% based on the current market price.
What is the FII and DII holding in Lincoln Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 4.60%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 44.37% of Lincoln Pharmaceuticals Ltd. shares.
What sector does Lincoln Pharmaceuticals Ltd. belong to?
Lincoln Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Lincoln Pharmaceuticals Ltd.?
The beta of Lincoln Pharmaceuticals Ltd. is 0.61, indicating its price volatility relative to the broader market. Over the past 1 year, Lincoln Pharmaceuticals Ltd. has delivered an absolute return of 4.98%.
What is the RSI of Lincoln Pharmaceuticals Ltd.?
The 14-day Relative Strength Index (RSI) of Lincoln Pharmaceuticals Ltd. is 36.60, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.